Inflammation

Items 31-40 of 52

per page
Set Descending Direction
  1. CD40 (human):Fc (human) (rec.)
    AG-40B-0083
    AG-40B-0083-C05050 µg
    CHF 300.00
    AG-40B-0083-30503 x 50 µg
    CHF 600.00
  2. CD40L (mouse) (multimeric) (rec.)
    AG-40B-0020
    AG-40B-0020-C01010 µg
    CHF 370.00
    AG-40B-0020-30103 x 10 µg
    CHF 740.00
  3. CD40L (mouse) (multimeric) (rec.) (Biotin)
    AG-40B-0020B
    AG-40B-0020B-C01010 µg
    CHF 400.00
    AG-40B-0020B-30103 x 10 µg
    CHF 800.00
  4. CD40L (rat) (multimeric) (rec.)
    AG-40B-0107
    AG-40B-0107-C01010 µg
    CHF 360.00
    AG-40B-0107-30103 x 10 µg
    CHF 720.00
  5. EDA-A1, Soluble (human) (rec.)
    AG-40B-0106
    AG-40B-0106-C01010 µg
    CHF 205.00
    AG-40B-0106-30103 x 10 µg
    CHF 410.00
  6. EDAR (human):Fc (human) (rec.)
    AG-40B-0116
    AG-40B-0116-C05050 µg
    CHF 290.00
    AG-40B-0116-30503 x 50 µg
    CHF 575.00
  7. Fas (human):Fc (human) (rec.)
    AG-40B-0082
    AG-40B-0082-C05050 µg
    CHF 300.00
    AG-40B-0082-30503 x 50 µg
    CHF 600.00
  8. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.
  9. Fc (human):FasL, Soluble (human) (rec.)
    AG-40B-0132
    AG-40B-0132-C01010 µg
    CHF 335.00
    AG-40B-0132-30103 x 10 µg
    CHF 670.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of MegaFasL, Soluble (human) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Pr
  10. Fc (human):RANKL, Soluble (mouse) (rec.)
    AG-40B-0059
    AG-40B-0059-C01010 µg
    CHF 265.00

Items 31-40 of 52

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.